Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selection.

BACKGROUND The influencing factors, especially time to treatment (TTT), for T1b/T2 gallbladder cancer (GBC) patients remain unknown. We aimed to identify the influencing factors on survival and surgical approaches selection for T1b/T2 GBC. METHODS We retrospectively screened GBC patients between January 2011 and August 2018 from our hospital. Clinical variables, including patient characteristics, TTT, overall survival (OS), disease-free survival (DFS), surgery-related outcomes, and surgical approaches were collected. RESULTS A total of 114 T1b/T2 GBC patients who underwent radical resection were included. Based on the median TTT of 7.5 days, the study cohort was divided into short TTT group (TTT ≤7 days, n = 57) and long TTT group (TTT >7 days, n = 57). Referrals were identified as the primary factor prolonging TTT (p < 0.001). There was no significance in OS (p = 0.790), DFS (p = 0.580), and surgery-related outcomes (all p > 0.05) between both groups. Decreased referrals (p = 0.005), fewer positive lymph nodes (LNs; p = 0.004), and well tumor differentiation (p = 0.004) were all associated with better OS, while fewer positive LNs (p = 0.049) were associated with better DFS. Subgroup analyses revealed no significant difference in survival between patients undergoing laparoscopic or open approach in different TTT groups (all p > 0.05). And secondary subgroup analyses found no significance in survival and surgery-related outcomes between different TTT groups of incidental GBC patients (all p > 0.05). CONCLUSIONS Positive LNs and tumor differentiation were prognostic factors for T1b/T2 GBC survival. Referrals associating with poor OS would delay TTT, while the prolonged TTT would not impact survival, surgery-related outcomes, and surgical approaches decisions in T1b/T2 GBC patients.

[1]  D. Stocken,et al.  Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  K. Hemminki,et al.  Long‐term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast , 2022, International journal of cancer.

[3]  Yoo-Seok Yoon,et al.  Comparative Study of Laparoscopic Versus Open Liver Resection in Gallbladder Cancer. , 2021, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[4]  Xiujun Cai,et al.  Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer , 2021, Frontiers in Oncology.

[5]  J. W. Kim,et al.  A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy. , 2021, European journal of cancer.

[6]  W. Lau,et al.  Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit , 2021, Frontiers in Oncology.

[7]  S. Raman,et al.  Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  Hong-Mei Yu,et al.  Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. , 2021, Surgery.

[9]  A. Zhu,et al.  Biliary tract cancer , 2021, The Lancet.

[10]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[11]  G. Molina,et al.  Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers , 2020, JAMA network open.

[12]  Fei Liu,et al.  Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China , 2020, Surgical Endoscopy.

[13]  Ying-bin Liu,et al.  Overview of current targeted therapy in gallbladder cancer , 2020, Signal Transduction and Targeted Therapy.

[14]  W. Bemelman,et al.  Safe, selective histopathological examination of gallbladder specimens: a systematic review , 2020, The British journal of surgery.

[15]  R. Coriat,et al.  The choice for the optimal therapy in advanced biliary tract cancers: Chemotherapy, targeted therapies or immunotherapy. , 2020, Pharmacology & therapeutics.

[16]  J. Vauthey,et al.  Comparison of oncological outcomes after open and laparoscopic re‐resection of incidental gallbladder cancer , 2019, The British journal of surgery.

[17]  W. Harmsen,et al.  Impact of delay to surgery on survival in stage I-III colon cancer. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  J. D'haese,et al.  Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox , 2019, Journal of Cancer Research and Clinical Oncology.

[19]  R. Makuuchi,et al.  Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  Qiuran Xu,et al.  A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. , 2019, Annals of translational medicine.

[21]  Prashanth Rawla,et al.  Epidemiology of gallbladder cancer , 2019, Clinical and experimental hepatology.

[22]  J. Raftery,et al.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. , 2019, The Lancet. Oncology.

[23]  A. Khorana,et al.  Time to initial cancer treatment in the United States and association with survival over time: An observational study , 2019, PloS one.

[24]  R. Makuuchi,et al.  Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer , 2018, Gastric Cancer.

[25]  M. Kojima,et al.  The prognostic impact of differentiation at the invasive front of biliary tract cancer , 2018, Journal of surgical oncology.

[26]  T. Pawlik,et al.  8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers , 2018, Annals of Surgical Oncology.

[27]  A. Zhu,et al.  New Horizons for Precision Medicine in Biliary Tract Cancers. , 2017, Cancer discovery.

[28]  Jeffrey E. Lee,et al.  Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer , 2017, Annals of Surgical Oncology.

[29]  K. Kawamoto,et al.  Laparoscopic approach to suspected T1 and T2 gallbladder carcinoma , 2017, World journal of gastroenterology.

[30]  T. Pawlik,et al.  Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium , 2017, JAMA surgery.

[31]  S. Shrikhande,et al.  Role of PET CT scan in redefining treatment of incidental gall bladder carcinoma , 2016, Journal of surgical oncology.

[32]  Z. Lou,et al.  CT pelvimetry and clinicopathological parameters in evaluation of the technical difficulties in performing open rectal surgery for mid-low rectal cancer , 2015, Oncology letters.

[33]  Eun Sun Lee,et al.  Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder carcinoma , 2015, Abdominal Imaging.

[34]  V. Sreenivas,et al.  Risk factors for gallbladder cancer: A case–control study , 2013, International journal of cancer.

[35]  I. Choi,et al.  The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  E. Shaffer,et al.  Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer , 2012, Gut and liver.

[37]  I. Ikai,et al.  Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: “narrow pelvis” is not a contraindication , 2011, Surgical Endoscopy.

[38]  C. Ko,et al.  Wait Times for Cancer Surgery in the United States: Trends and Predictors of Delays , 2011, Annals of surgery.

[39]  J. Llamas-Elvira,et al.  Application of modern imaging methods in diagnosis of gallbladder cancer , 2006, Journal of surgical oncology.

[40]  T. Oshikiri,et al.  Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.